CLOLAR Trademark

Trademark Overview

On Wednesday, December 12, 2012, a trademark application was filed for CLOLAR with the United States Patent and Trademark Office. The USPTO has given the CLOLAR trademark a serial number of 85800469. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, February 20, 2024. This trademark is owned by Genzyme Corporation. The CLOLAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and autoimmune disease in the field of oncology
clolar

General Information

Serial Number85800469
Word MarkCLOLAR
Filing DateWednesday, December 12, 2012
Status800 - REGISTERED AND RENEWED
Status DateTuesday, February 20, 2024
Registration Number4372276
Registration DateTuesday, July 23, 2013
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Description of MarkThe mark consists of the word "CLOLAR" followed by an arrow-like shape consisting of two triangles.
Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune disease in the field of oncology
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 21, 2012
Primary Code005
First Use Anywhere DateWednesday, June 20, 2012
First Use In Commerce DateWednesday, June 20, 2012

Trademark Owner History

Party NameGenzyme Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, December 22, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Saturday, December 15, 2012NEW APPLICATION ENTERED
Friday, December 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, March 28, 2013ASSIGNED TO EXAMINER
Thursday, March 28, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2013REGISTERED-PRINCIPAL REGISTER
Monday, February 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 14, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, July 23, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 12, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 12, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 21, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, March 14, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, March 14, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, July 23, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 25, 2023TEAS SECTION 8 & 9 RECEIVED
Tuesday, February 20, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 20, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, February 20, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, February 20, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

clolar disease field oncology autoimmune cancer preparations treatment pharmaceutical